IMVOTAMAB

UNII:	F3HG38I0T1
Formula:
Preferred Substance Name:	IMVOTAMAB
GSRS Full Record:	F3HG38I0T1 i

2573121-53-4
ANTI-CD20/ANTI-CD3 BISPECIFIC IGM ANTIBODY IGM2323
IGM2323
IGM-2323
IMMUNOGLOBULIN M, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN .MU.-CHAIN), DISULFIDE WITH HUMAN .KAPPA.-CHAIN, DECAMER, (574'->271),(574''''''''''->325)-BIS(DISULFIDE) WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN SINGLE-CHAIN FV FRAGMENT VH-(GGGGS)3-VL) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)3 FUSION PROTEIN WITH IMMUNOGLOBULIN J CHAIN (HUMAN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)3 FUSION PROTEIN WITH SERUM ALBUMIN (HUMAN)
IMVOTAMAB [INN]
IMVOTAMAB [USAN]
IMVOTAMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

IMVOTAMAB

Synonyms and Mappings

Resources